CareDx has appointed John W. Hanna as its new President and Chief Executive Officer, and member of the Company’s Board of Directors, effective April 15, 2024. Hanna brings to CareDx over two decades of executive leadership at the intersection of new technology development and revenue growth in the molecular diagnostics and life sciences tools industries.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx to present cardiothoracic advancements at 2024 ISHLT meeting
- CareDx Enhances Board with Financial Expert Riggsbee
- CareDx turns positive with CMS transplant update seen as positive
- CMS announcement positive for CareDx and Natera, says Craig-Hallum
- CMS says transplant patients can continue to access blood tests
